I concur, great charting and it looks like yours and Sojo's expertise will continue to bring a lot of positive color to this board. Looking forward to many more charts.

Looks great, I would like a repeat after topline to see those fans and the skyscraper. Would create a nice picture to hang over the fireplace. Hoping the fans only penetrate the first few floors of the skyscraper when seen from a complete historical aspect.

Wait until they are forced to display real life 3 year and 5 year data when NWBO hits the airwaves. When this happens their stock will plummet below 20 per share and eventually dwindle to nothing. They are racing to get approval in other indications knowing if they do not they will not survive as a real treatment option in the cancer space. I believe as competitors they are one of the reasons this stock has been shorted to oblivion. IMO.

Just remember for that article they knew they wanted to wait 5 years for all patients but did not want to publicize so intentionally strung that publication out as long as they could. Will not be the same in this case.

You never know Anders, once you have a lot more to play with chasing the big ticket biotechs might not be such an issue considering the payoffs. Hoping all of us have the luxury of being much more flexible with future portfolios. This board has been an addiction long enough, looking forward to the next addiction whatever that may be.

Truth in this statement as B/O will have happened way before, and long term warrant holders will maximize their profits instead of selling short. Everyone in this scenario wins regardless of how the warrant extension plays out. I believe great news in almost upon us. GLA

For me a BO is still in play so an extension makes sense in that on release of TLD we get liftoff in terms of SP. Once the appropriate price point is reached the BO is then made public. Those extended warrants were never going to be part of this equation just protecting the SP between release of TLD and BO/Partnership announcement.
My guess is TLD is made public soon and early January we get BO announcement.
In between TLD and BO will be a slew of PR's to build SP to get to the magic number. IMO. GLA

No I agree, I am just stating that this gives them a heads up that TLD is delayed and they can therefor trade shares in the knowledge that they can buy back on the swings. Mini pumps and dumps as we have seen for years with this stock.

So now we know that these shareholders who are privileged to inside information regarding warrant extensions and therefor TLD delay have been the ones selling these past weeks. This type of profit taking by fellow shareholders at the expense of truly blinded shareholders have seen them benefit greatly these past number of years. Hopefully this BS ends soon.

Yep looks like another magical spot of many thousands in Europe, so much History and charm practically any place you decide to take a detour. Will do a tour again in the future. Meantime we wait for the magic of NWBO to begin.

Don't forget to visit Delft, a hidden gem and a place I used to stay while working in Den Haag on and off for many years. Have many great memories of my time in Europe and Delft was one of many places that has a bit of magic.

So you are confirming that warrants have now been extended through the end of December and not December 15th. Correct?

Here you go ATL - a detailed guide on the Clinical Trials website explaining how to update your own webpage. Forward it to DI and tell him to get on it and show us that he can do something that will silence all those annoying phone calls he keeps getting.

How to Edit Your Study Record
Contents
Editing and Updating a Record
View Earlier Versions of Your Study Record
Editing and Updating a Record
This page describes the overall process of editing a record. If you would like step-by-step instructions for registering a study or entering results information into the PRS, see the PRS Guided Tutorials. [Requires a browser that supports HTML5.]

At any time, you can make updates and edits to a record published on ClinicalTrials.gov by logging into the Login to ClinicalTrials.gov PRS and clicking on Edit Record under the Protocol Records heading on the PRS main menu. After you finish making changes, you will need to release (submit) the record to ClinicalTrials.gov for review and processing. See the ClinicalTrials.gov Protocol Review Criteria (PDF) for a description of items that should be addressed before releasing the record to ClinicalTrials.gov. See the ClinicalTrials.gov Protocol Information Review Process for more information.

Required Registration Updates
Responsible Parties should update their records within 30 days of a change to any of the following:

Recruitment Status and Overall Recruitment Status data elements on ClinicalTrials.gov
Completion Date (See Primary Completion Date data element on ClinicalTrials.gov)
Other changes or updates to the record, such as protocol amendments, must be made at least every 12 months. It is recommended that the Record Verification Date be updated at least every 6 months for studies that are not yet completed, even if there were no changes to the record.

So ATL tell me why would NWBO not update the clinical website with the endpoints now that the cat is out of the bag so too speak over in Europe. You make absolutely no sense as even DI could accomplish this task in no more than a couple of hours. This very simple task would confirm to the market that the FDA has also bought into these critical new endpoints and would serve to silence the doubters even more. This very simple task would have a huge impact on the share price prior to DL and serve to silence all the shareholders leading up to DL. Literally DI would be fielding 90% less calls if he spent a tiny bit of time confirming the endpoints.

I have always agreed with BSB and Flipper regarding a rather large whale that has been eyeing up NWBO for some time now. I believe we will see a large reversal in a positive direction regarding SP shortly in anticipation of buyout. Shorts and traders dealing in pennies right now will be roasted. IMO.

This sounds like a completely manufactured e-mail. Company is somewhat blinded, what the hell does that mean. The company is supposedly in a quiet period and I cannot believe that this post has any credibility at all. Believe these types of post at your peril.

No matter what garbage they throw at the NWBO wall it's not sticking and we can see that by the reluctance by any longs to sell into the manufactured FUD being generated over this weekend. That must be highly frustrating for these fudsters as they are finding it almost impossible to loosen any shares created by this solid WALL of support for NWBO. Their time to cover at much higher prices is fast approaching and expect their incessant whining to reach a fever pitch the closer that time approaches.

That is exactly what I saw and the main reason that I think Merck is behind closed doors with NWBO penning a deal.

I have been pestered lately by Fidelity to have me borrow my shares for these shorts. Looks like an attack is coming this week as they have been emboldened by the cancellations as of late.

To update the endpoints on this particular page would take someone even with limited knowledge no more than a couple of hours. Do you really think that they are so tied up that they could not do this simple task.
This inability to update a simple page with data that can be copied and pasted in, just serves to sow doubt which feeds the shorts. As Flipper has alluded are they still trying to ensnare their enemies which I doubt as they have so much more important tasks to achieve at this point.
Delivering stellar topline would be enough to crush any shorts that have targeted this company for all these years.
I agree with BSB that if the endpoints have been accepted by the FDA then NWBO owes it to to its shareholders to do the very simple task of updating the Clinical trials webpage.
Maybe Sentiment can request DI to personally oversee this very easy task which would in one swift moment support and grow the SP through to topline.
If NWBO refuse to do this task then we have to assume that the FDA has not agreed to the new endpoints.

I think what he wanted you to read is the part which states that they would be preparing the data for Public Announcement and publication. The public announcement would be a PR of topline which could come anytime over the coming weeks. I believe they would also be looking to release the data in a journal after topline to expand on the bullet points displayed in the TLD PR. No matter what noise is being made regarding conferences and the negativity brought on by disgruntled longs the simple fact from the Oct 5th PR is that we as shareholders should be waiting for a PR not conference. Shorts and traders may be jumping on this negativity come Monday morning but even they know that on any given day going forward TLD could be announced. Will the risk of shorting this stock on an ongoing basis be worth the risk of being blind sided at any given moment be worth it, I do not think so. However, expect an attack on the share price but if longs and new shareholders keep their cool then this attack will be brief. I fully expect a quick recovery as we then sit back and wait for what should be a stellar TLD PR. Each day that passes is a step nearer a beautiful day and also a step nearer the abyss for those that try to prey on weakness. Stay strong and you shall be richly rewarded IMO.

Thanks for getting the real facts again. Very strange that SITC representatives would be sending out misinformation and not correct their error and remove the place holding. Looks like the only thing that everyone on this board should rely on is actual communication from the company.

Why are you parading this message for the last couple of days when pablo clearly got an answer from SITC that an abstract has been received. Would you not think that SITC would remove the event if they believe they have errored once they have been contacted by the public on this specific poster event.

Has it even been confirmed that they are attending ESMO?

Surely a quick e-mail to Dave Innes now that the SITC information is public domain asking him if NWBO will or will not be attending SITC is a fair question. It looks like the shorts know the answer as I am getting calls from Fidelity asking to borrow my shares. The misinformation out there if it is indeed misinformation is only helping traders and shorts. The longs hopes are continually dashed because of poor communication regarding such important events such as SNO and SITC. Maybe SITC is part of an elaborate plan to hammer the fudsters but that would be wishful thinking and due to past history I am already doubting myself. Good luck all.

Agree on this, looks like the perfect trap has been sprung and the shorts are about to be royally roasted. TLD could come tomorrow, a perfect hammer strike.

Agree 100% with Sojo on this one. Why would you need 3 to present the endpoint changes, makes no sense at all. You need to think a little more outside the box. Far more is in play than just TLD.

Agree with BSB regarding BO simply based on what we have been seeing and with regard the ageing NWBO crew who have little to offer when it comes to scaling DCVAX to its full potential.
Once buyout has been achieved can you imagine how quickly that money will pour back into Merck. I know I will be buying their shares hand over fist to establish a position in a future trillion plus company.

Great find, and the nice piece in there says

Phase III Clinical Trial to Test the Safety and Efficacy of Autologous Tumor Lysate-Loaded Dendritic Cells in Patients with Newly Diagnosed Glioblastoma

AND

Category - Completed Clinical Trials.

Any day now TLD will hit the airwaves and BOOM.

Cherry, had the same thoughts concerning both the rise and then takedown so close to topline. This looks like a coordinated effort by nefarious forces to try and dislodge as many shares possible before the inevitable good news which will then take the SP north of $5.
I do agree with BSB that a deal is in hand so this was possibly their last chance to scare more shares into their hands to cover positions or simply steal to coin a phrase from less informed investors.
I think that TLD will be closely followed by partnership/buyout news which will completely negate the impact of any dilution with warrants.

Glad you are on the mend, missed the bucking bronco this morning, I am sure there will be a lot more bucking before TLD though.

Well said diver, with you 100% with the future impact of this type of vaccine not just in our fight against cancer but all diseases that plague our bodies. Immunotherapy is a truly holistic therapy that will be loved by all and NWBO’s story is just beginning.

Wishing the very best outcome for your sister and long may her fight continue. Many of us on this board have had loved ones afflicted with this disease and it is one of the most important reasons why we so dearly love the technology of DCVAX which we hope will lead the way in our fight against the scourge that has plagued our families.

This ride has only just begun. Linda Powers always talks about DCVAX-L and D as platform technologies. As the world awakens to this fact what we will witness will be incredible. Predicting pps as some on here are trying to do is fruitless. Just know the value of what you are holding. This is an investment of a lifetime and NWBO will become the most storied biotech of all time. Immunotherapy as a real technology to treat all cancers is about to hit the airwaves and when it does watch out.

Hi Tryn2, congrats first of all and glad to see you and your wife reach a solid agreement on where you will cover your investment. I am pretty much in the same boat and my wife and I have tremendous belief in this great little company. I have said many times on this board that this is a gold bar investment and each share should be treated as such. We are on the cusp of something extraordinary and with the recent acceptance of new endpoints the value has increased exponentially in the short term which of course will allow many to trade in a few gold bars to cover their initial investments just in case the 1% wins.

Another point to remember post TLD is because most of the shares will be held by friendlies and long term longs guess who will be willing to continue financing the company going forward. Many on this board who are currently small time retail may along with already established friendly financiers be in a position to support the company post TLD with new wealth. NWBO in effect could be financed by a much larger set of financiers who know what this company will become in the future and that is an overall leader in cancer care. This is of course if NWBO go it alone.

I was just making the point that we live in a capitalist world where making money is just a part of the game. The odds are just more firmly stacked with those in the know and those already with a load of capital. I am not criticizing anyone for making money and if I were in the same position I would do the same.

Yup, basically in the past themoo and his crew would sell off all their discounted shares to retail make a healthy profit and effectively pass all the risk to retail. They would be left with a healthy number of warrants that they effectively would get at very discounted prices. The finance would effectively be passed on to retail and the ones in the know have no risk but a boatload of warrants. This type of financing as we have seen has been repeated multiple times in the past and the ones in the know have always made money and achieve 0 risk.

Maybe they really do have it in for the enemies of this company and were not willing to share this information up front to allow covering of positions. It just shows the confidence they have in achieving their goals and at the same time burying their enemies once and for all. The revelation was a shot in the dark and unexpected. Now that it is open theatre all parties on all sides can re-address their positions. I believe we will see covering happening right into topline as well as new investors in there droves.

Sellers remorse is sinking in after the recent news concerning the endpoints. This remorse leads you to bitterness and shows that you have never really believed in this technology hence the quick sell in the 60's.